{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:05:08Z","timestamp":1792508708192,"version":"4.5.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1093\/jnci\/djv002","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T04:31:14Z","timestamp":1423542674000},"source":"Crossref","is-referenced-by-count":85,"title":["Effect of Prior Cancer on Outcomes in Advanced Lung Cancer: Implications for Clinical Trial Eligibility and Accrual"],"prefix":"10.1093","volume":"107","author":[{"given":"Andrew L.","family":"Laccetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandi L.","family":"Pruitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan A.","family":"Halm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,9]]},"reference":[{"issue":"3","key":"key\n\t\t\t\t20170520225441_CIT0001","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncr.22436","article-title":"Provider roles in the recruitment of underrepresented populations to cancer clinical trials","volume":"109","author":"Howerton","year":"2007","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170520225441_CIT0002","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/1097-0142(19900515)65:10+<2376::AID-CNCR2820651504>3.0.CO;2-A","article-title":"National Cancer Institute sponsored cooperative clinical trials","volume":"65","author":"Friedman","year":"1990","journal-title":"Cancer"},{"issue":"22","key":"key\n\t\t\t\t20170520225441_CIT0003","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: race-, sex-, and age-based disparities","volume":"291","author":"Murthy","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"key\n\t\t\t\t20170520225441_CIT0004","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1200\/JCO.2001.19.6.1728","article-title":"Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment","volume":"19","author":"Lara","year":"2001","journal-title":"J Clin Oncol"},{"issue":"27","key":"key\n\t\t\t\t20170520225441_CIT0005","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1200\/JCO.2007.15.3726","article-title":"Identification of cancer care and protocol characteristics associated with recruitment in breast cancer clinical trials","volume":"26","author":"Lemieux","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170520225441_CIT0006","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/1740774512456453","article-title":"Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment","volume":"9","author":"Filion","year":"2012","journal-title":"Clin Trials"},{"issue":"5","key":"key\n\t\t\t\t20170520225441_CIT0007","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1634\/theoncologist.2008-0268","article-title":"The impact of consenter characteristics and experience on patient interest in clinical research","volume":"14","author":"Rasco","year":"2009","journal-title":"Oncologist"},{"issue":"2","key":"key\n\t\t\t\t20170520225441_CIT0008","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cncr.21613","article-title":"Factors influencing inclusion of patients with malignancies in clinical trials","volume":"106","author":"Tournoux","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"key\n\t\t\t\t20170520225441_CIT0009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1200\/JOP.2011.000335","article-title":"Consent timing and experience: modifiable factors that may influence interest in clinical research","volume":"8","author":"Gerber","year":"2012","journal-title":"J Oncol Pract"},{"issue":"1","key":"key\n\t\t\t\t20170520225441_CIT0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/02841860600849067","article-title":"A short communication course for physicians improves the quality of patient information in a clinical trial","volume":"46","author":"Hietanen","year":"2007","journal-title":"Acta Oncol"},{"issue":"22","key":"key\n\t\t\t\t20170520225441_CIT0011","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2004.02.175","article-title":"Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration","volume":"22","author":"Talarico","year":"2004","journal-title":"J Clin Oncol"},{"issue":"12","key":"key\n\t\t\t\t20170520225441_CIT0012","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0895-4356(99)00141-9","article-title":"Barriers to participation in randomised controlled trials: a systematic review","volume":"52","author":"Ross","year":"1999","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"key\n\t\t\t\t20170520225441_CIT0013","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/1097-0142(19830915)52:6<1014::AID-CNCR2820520614>3.0.CO;2-J","article-title":"Accrual of radiotherapy patients to clinical trials","volume":"52","author":"Lee","year":"1983","journal-title":"Cancer"},{"issue":"17","key":"key\n\t\t\t\t20170520225441_CIT0014","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/djq291","article-title":"A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program","volume":"102","author":"Scoggins","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"key\n\t\t\t\t20170520225441_CIT0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1200\/JOP.2013.001119","article-title":"The National Cancer Institute-American Society of Clinical Oncology cancer trial accrual symposium: summary and recommendations","volume":"9","author":"Denicoff","year":"2013","journal-title":"J Oncol Pract"},{"issue":"6","key":"key\n\t\t\t\t20170520225441_CIT0016","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1179\/102453310X12719010991623","article-title":"Evaluation of factors associated with recruitment in hematological clinical trials: a retrospective cohort study","volume":"15","author":"Lemieux","year":"2010","journal-title":"Hematology"},{"issue":"11","key":"key\n\t\t\t\t20170520225441_CIT0017","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.297.11.1233","article-title":"Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review","volume":"297","author":"Van Spall","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"key\n\t\t\t\t20170520225441_CIT0018","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00000421-198204000-00072","article-title":"Cancer patient accessions into clinical trials: a pilot investigation into some patient and physician determinants of entry","volume":"5","author":"McCusker","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"key\n\t\t\t\t20170520225441_CIT0019","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jso.2930500215","article-title":"Reasons for non-entry in randomized clinical trials for breast cancer: a single institutional study","volume":"50","author":"Kotwall","year":"1992","journal-title":"J Surg Oncol"},{"issue":"11","key":"key\n\t\t\t\t20170520225441_CIT0020","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju302","article-title":"Impact of prior cancer on eligibility for lung cancer clinical trials","volume":"106","author":"Gerber","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"key\n\t\t\t\t20170520225441_CIT0021","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/1055-9965.EPI-12-1356","article-title":"Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care","volume":"22","author":"de Moor","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"key\n\t\t\t\t20170520225441_CIT0022","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ejcts.2008.08.004","article-title":"Multiple independent primary cancers do not adversely affect survival of the lung cancer patient","volume":"34","author":"Aguilo","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"key\n\t\t\t\t20170520225441_CIT0023","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/thx.2005.051615","article-title":"Previous tumour as a prognostic factor in stage I non-small cell lung cancer","volume":"62","author":"Lopez-Encuentra","year":"2007","journal-title":"Thorax"},{"issue":"4","key":"key\n\t\t\t\t20170520225441_CIT0024","first-page":"1152","article-title":"Second primary tumors involving non-small cell lung cancer: prevalence and its influence on survival","volume":"127","author":"Duchateau","year":"2005","journal-title":"Chest"},{"issue":"2","key":"key\n\t\t\t\t20170520225441_CIT0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0169-5002(01)00408-1","article-title":"Multiple primary malignancies involving lung cancer-clinical characteristics and prognosis","volume":"35","author":"Liu","year":"2002","journal-title":"Lung Cancer"},{"issue":"5","key":"key\n\t\t\t\t20170520225441_CIT0026","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S1010-7940(00)00571-6","article-title":"Lung cancer following previous extrapulmonary malignancy","volume":"18","author":"Massard","year":"2000","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"key\n\t\t\t\t20170520225441_CIT0027","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s005950050171","article-title":"Clinical study on lung cancer as a second primary cancer","volume":"28","author":"Utsumi","year":"1998","journal-title":"Surg Today"},{"key":"key\n\t\t\t\t20170520225441_CIT0028","doi-asserted-by":"crossref","first-page":"IV\u20133","DOI":"10.1097\/00005650-200208001-00002","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"key\n\t\t\t\t20170520225441_CIT0029","volume-title":"SEER Cancer Statistics Review, 1975\u20132007","author":"Altekruse"},{"key":"key\n\t\t\t\t20170520225441_CIT0030","article-title":"Attachment A for the SEER-Medicare PEDSF File SEER Research Data Record Description Cases Diagnosed in 1973-2009","volume-title":"SEER-Medicare Technical Support, Information Management Services, Inc. SEER historic stage A"},{"key":"key\n\t\t\t\t20170520225441_CIT0031","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2407-14-272","article-title":"Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study","volume":"14","author":"Coyte","year":"2014","journal-title":"BMC Cancer"},{"issue":"24","key":"key\n\t\t\t\t20170520225441_CIT0032","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"key\n\t\t\t\t20170520225441_CIT0033","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cllc.2013.06.009","article-title":"Influence of Medical Comorbidities on the Presentation and Outcomes of Stage I-III Non-Small-Cell Lung Cancer","volume":"14","author":"Ahn","year":"2013","journal-title":"Clin Lung Cancer"},{"issue":"12","key":"key\n\t\t\t\t20170520225441_CIT0034","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jnci\/djn175","article-title":"Evaluation of trends in the cost of initial cancer treatment","volume":"100","author":"Warren","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"key\n\t\t\t\t20170520225441_CIT0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"key\n\t\t\t\t20170520225441_CIT0036","volume-title":"SEER-Medicare: Calculation of comorbidity weights","author":"National Cancer Institute"},{"issue":"1","key":"key\n\t\t\t\t20170520225441_CIT0037","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1475-6773.2009.01051.x","article-title":"The utility of the state buy-in variable in the Medicare denominator file to identify dually eligible Medicare-Medicaid beneficiaries: a validation study","volume":"45","author":"Koroukian","year":"2010","journal-title":"Health Serv Res"},{"key":"key\n\t\t\t\t20170520225441_CIT0038","doi-asserted-by":"crossref","DOI":"10.1002\/9780470258019","volume-title":"Applied Survival Analysis: Regression Modeling of Time to Event Data","author":"Hosmer","year":"2008"},{"issue":"1","key":"key\n\t\t\t\t20170520225441_CIT0039","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0169-5002(00)00208-7","article-title":"The prognostic significance of a previous malignancy in operable non-small cell lung cancer","volume":"32","author":"Koppe","year":"2001","journal-title":"Lung Cancer"},{"issue":"9","key":"key\n\t\t\t\t20170520225441_CIT0040","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1185\/03007995.2013.816276","article-title":"Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review","volume":"29","author":"Nandy","year":"2013","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"key\n\t\t\t\t20170520225441_CIT0041","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1634\/theoncologist.2011-0214","article-title":"Second malignancies among elderly survivors of cancer","volume":"16","author":"VanderWalde","year":"2011","journal-title":"Oncologist"},{"issue":"11","key":"key\n\t\t\t\t20170520225441_CIT0042","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1158\/1055-9965.EPI-06-0414","article-title":"The epidemiology of second primary cancers","volume":"15","author":"Travis","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"key\n\t\t\t\t20170520225441_CIT0043","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"key\n\t\t\t\t20170520225441_CIT0044","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program","volume":"12","author":"Hayat","year":"2007","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t20170520225441_CIT0045","doi-asserted-by":"crossref","DOI":"10.1016\/B978-1-4557-2865-7.00083-7","article-title":"Chapter 83 - Bladder Cancer","volume-title":"Abeloff\u2019s Clinical Oncology","author":"Smith","year":"2014","edition":"5th"},{"issue":"2","key":"key\n\t\t\t\t20170520225441_CIT0046","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10428190802645061","article-title":"Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy","volume":"50","author":"Pulte","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"key\n\t\t\t\t20170520225441_CIT0047","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/annonc\/mdq078","article-title":"Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor","volume":"21","author":"Pandurengan","year":"2010","journal-title":"Ann Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170520225441_CIT0048","first-page":"180","article-title":"Survival in colorectal carcinoma associated with previous extracolonic cancer","volume":"76","author":"Varty","year":"1994","journal-title":"Ann R Coll Surg Engl"},{"issue":"21","key":"key\n\t\t\t\t20170520225441_CIT0049","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2008.20.8793","article-title":"Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics","volume":"27","author":"Gandara","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170520225441_CIT0050","first-page":"25","article-title":"Prognostic factors for survival in patients with inoperable lung cancer","volume":"65","author":"Stanley","year":"1980","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"key\n\t\t\t\t20170520225441_CIT0051","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/JTO.0b013e3181e9a00f","article-title":"Looking beyond surveillance, epidemiology, and end results: patterns of chemotherapy administration for advanced non-small cell lung cancer in a contemporary, diverse population","volume":"5","author":"Rasco","year":"2010","journal-title":"J Thorac Oncol"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/107\/4\/djv002\/17314091\/djv002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:07:13Z","timestamp":1651205233000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djv002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,9]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,2,9]]},"published-print":{"date-parts":[[2015,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djv002","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2,9]]}}}